Anti-GNAS3/ GNAS2/ ALEX monoclonal antibody

Anti-GNAS3/ GNAS2/ ALEX antibody for FACS & in-vivo assay

Target products collectionGo to GNAS/GNAS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2144-Ab-1/ GM-Tg-hg-MP2144-Ab-2Anti-Human GNAS monoclonal antibodyHuman
GM-Tg-rg-MP2144-Ab-1/ GM-Tg-rg-MP2144-Ab-2Anti-Rat GNAS monoclonal antibodyRat
GM-Tg-mg-MP2144-Ab-1/ GM-Tg-mg-MP2144-Ab-2Anti-Mouse GNAS monoclonal antibodyMouse
GM-Tg-cynog-MP2144-Ab-1/ GM-Tg-cynog-MP2144-Ab-2Anti-Cynomolgus/ Rhesus macaque GNAS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2144-Ab-1/ GM-Tg-felg-MP2144-Ab-2Anti-Feline GNAS monoclonal antibodyFeline
GM-Tg-cang-MP2144-Ab-1/ GM-Tg-cang-MP2144-Ab-2Anti-Canine GNAS monoclonal antibodyCanine
GM-Tg-bovg-MP2144-Ab-1/ GM-Tg-bovg-MP2144-Ab-2Anti-Bovine GNAS monoclonal antibodyBovine
GM-Tg-equg-MP2144-Ab-1/ GM-Tg-equg-MP2144-Ab-2Anti-Equine GNAS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2144-Ab-1/ GM-Tg-hg-MP2144-Ab-2; GM-Tg-rg-MP2144-Ab-1/ GM-Tg-rg-MP2144-Ab-2;
GM-Tg-mg-MP2144-Ab-1/ GM-Tg-mg-MP2144-Ab-2; GM-Tg-cynog-MP2144-Ab-1/ GM-Tg-cynog-MP2144-Ab-2;
GM-Tg-felg-MP2144-Ab-1/ GM-Tg-felg-MP2144-Ab-2; GM-Tg-cang-MP2144-Ab-1/ GM-Tg-cang-MP2144-Ab-2;
GM-Tg-bovg-MP2144-Ab-1/ GM-Tg-bovg-MP2144-Ab-2; GM-Tg-equg-MP2144-Ab-1/ GM-Tg-equg-MP2144-Ab-2
Products NameAnti-GNAS monoclonal antibody
Formatmab
Target NameGNAS
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GNAS benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GNAS3/ GNAS2/ ALEX VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMAP000010Human GNAS Adenovirus plasmid
    ORF Viral VectorvGMAP000011Human GNAS Adenovirus particle
    ORF Viral VectorvGMAP000010Human GNAS Adenovirus particle
    ORF Viral VectorvGMAP000061Human GNAS Adenovirus particle
    ORF Viral VectorpGMAP000011Human GNAS Adenovirus plasmid
    ORF Viral VectorvGMLP003886human GNAS Lentivirus particle
    ORF Viral VectorpGMAP000061Human GNAS Adenovirus plasmid
    ORF Viral VectorpGMLP003886human GNAS Lentivirus plasmid


    Target information

    Target IDGM-MP2144
    Target NameGNAS
    Gene ID2778,14683,24896,281793
    Gene Symbol and Synonyms5530400H20Rik,A930027G11Rik,AHO,ALEX,C130027O20Rik,C20orf45,G-alpha-8,Galphas,GNAS,GNAS1,Gnasxl,Gnpas,GPSA,Gs-alpha,GSA,GSP,NESP,Nesp55,Nespl,Oed-Sml,Oedsml,P1,P2,P3,PHP1A,PHP1B,PITA3,POH,SCG6,SgVI
    Uniprot AccessionO95467, P63092, P84996, Q5JWF2,P63095,Q63803,Q792G6,Q9Z213,P63091,O18979,P04896
    Uniprot Entry NameGNAS2_RAT,GNAS1_RAT,GNAS3_RAT,ALEX_RAT,GNAS_CANLF,GNAS3_BOVIN,GNAS2_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000087460
    Target ClassificationTumor-associated antigen (TAA)

    The target: GNAS, gene name: GNAS, also named as AHO, C20orf451, GPSA, GSA, GSP, NESP, PITA3, POH, SCG6, SgVI, GNAS. This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.